TXNIP and Alzheimer disease: Recent studies suggest that T2DM (neurovascular-disorder) has not shown any significant correlation with associated biomarkers in mild cognitive disorders in AD, and PD (neurodegenerative-disorders) pathologies [115], although the common biomarkers they tested for reference disorders do not include TXNIP which can be studied in this context.